New Guidance Outlining Total Artificial Disc Trial Design Issued
This article was originally published in The Gray Sheet
Executive Summary
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance